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Source, Occurrence, and Fate of Pharmaceuticals in Natural 
Waters 
Abstract 
The consumption of pharmaceuticals has increased in the last few decades. After usage, 
pharmaceuticals are excreted via urine and feces and transported to wastewater 
treatment plants (WWTPs) where they are subjected to treatment processes, and finally 
discharged into rivers. In order to assess aquatic risk associated with short- and long-
term exposure to pharmaceuticals, temporal-spatial variability in the concentrations 
should be monitored in different water compartments. In this thesis, occurrence and fate 
of pharmaceuticals and other organic pollutants were studied in Swedish and Canadian 
rivers and WWTPs, and the major sources of contaminations were identified.  
The ranges of mean concentrations of the pharmaceuticals and personal care 
products (PPCPs), hormones, and pesticides were 2.4-13755 ng L
-1 and 0.5-112 ng L
-1 
in treated wastewaters and rivers, respectively. WWTPs and combined sewer overflows 
(CSOs) were identified as major sources of PPCPs in rivers. However, a large gathering 
of people at a river shore could temporarily contribute to a high input of 
pharmaceuticals. A temporal study of mass flows and corresponding removal 
efficiencies (REs) of WWTP-derived pharmaceuticals showed winter accumulations for 
most of the compounds. This might reflect high water flow rates and negligible rates of 
bio- and phototransformation in this season. REs of beta-blockers were season-
dependent, with the highest removal in the summer and fall. This was due to 
biotransformation, indicated by high water temperature and chlorophyll a mass flows 
during those seasons. Yearly median REs of nutrients were low compared to 
pharmaceuticals. Yet, REs of atenolol and nitrate-nitrogen (NO3-N) were related and 
had similar seasonal trends. Carbamazepine REs were the lowest among the 
pharmaceuticals. The latter combined with the persistence of carbamazepine in 
WWTPs and a lake showed its potential as an indicator of cumulative contamination. A 
correlation between caffeine concentrations and fecal coliforms in rivers confirmed 
caffeine as an indicator of recent urban fecal contamination. A high 
caffeine/carbamazepine ratio might be indicative of raw sewage discharge in a river, 
justified by higher concentrations of caffeine than carbamazepine in raw sewage and 
negligible removal of carbamazepine in WWTPs. The outcomes of the thesis show that 
source characteristics, water flow rates, and environmental conditions are essential 
factors that control detection frequency, concentrations and associated mass flows, and 
the fate of pharmaceuticals in aquatic environments. Also, pharmaceuticals can be used 
as indicators of recent and cumulative fecal contamination in drinking water sources. 
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1 Introduction 
Pharmaceuticals and personal care products (PPCPs), and hormones refer to a 
large class of chemical contaminants that are produced and consumed in large 
quantities worldwide. They are introduced directly into wastewater treatment 
plants (WWTPs) through different pathways including household and 
consumer products, excretion in forms of parent compounds and/or metabolites 
with feces and urine, disposal of unused or expired medicine in toilets, and 
hospital waste (Heberer, 2002; Daughton & Ternes, 1999; Halling-Sørensen et 
al., 1998). Various works have reported that PPCPs and hormones are not 
totally eliminated in WWTPs by the available treatment techniques, therefore, 
complex mixtures of partially eliminated contaminants as well as their 
metabolites are continuously released into surface waters (Yoon et al., 2010; 
Vieno et al., 2006). 
The first reports on steroid hormones occurring in municipal wastewater 
were published in the United States in the mid-1960s and early 1970s (Tabak 
& Bunch, 1970; Stumm-Zollinger & Gordon, 1965). A couple of years later, 
studies in the United States reported the occurrence of clofibric acid and 
salicylic acid in wastewater effluents (Garrison, 1977; Hignite & Azarnoff, 
1977). However, the first European report highlighting the presence of 
synthetic steroids in treated wastewaters and rivers was published one decade 
later in the UK (Aherne & Briggs, 1989). The presence of PPCPs in aquatic 
environments received great attention in the late 1990s, shortly after 
demonstrating that endocrine disruption in fish is related to natural and 
synthetic estrogens (Desbrow et al., 1998; Routledge et al., 1998). Since then, 
a growing body of work has been published on this topic worldwide (Kim et 
al., 2007; Castiglioni et al., 2005; Zuccato et al., 2005; Heberer, 2002; Kolpin 
et al., 2002; Daughton & Ternes, 1999; Buser et al., 1998; Halling-Sørensen et 
al., 1998; Ternes, 1998).  
In the 1970s, a preliminary list of priority pollutants was established in the 
United States, mainly based on the availability of analytical techniques 14 
allowing for detection at low concentrations in aqueous matrices (Daughton, 
2003). Three decades later, in 2000, a first list of 33 priority substances had 
been established within the context of the EU Water Framework Directive 
(WFD) (2000/60/EC) with updates every four years since then (Ellis, 2006). 
The priority substances were chosen according to their toxicity, persistency, 
and liability to bioaccumulation or similar qualities which give rise to an 
equivalent level of concern (Ellis, 2006). In the latest revision of the WFD in 
2012, two hormones, i.e. 17 alpha-ethinylestradiol and 17 beta-estradiol, and 
one pharmaceutical, i.e. diclofenac were among 15 additional substances 
proposed for incorporation into the priority list (European Commission 2011). 
During the last couple of years, sources and occurrence of PPCPs and 
hormones in different environmental compartments, especially water, have 
been studied in detail. Yet, there is little data available from specific 
geographical regions, and a significant knowledge gap exists in terms of their 
fate in natural waters. Consumption of PPCPs and hormones is increasing (3-
4% by weight annually) (Ellis, 2006) and new compounds are continually 
being manufactured (Yu et al., 2006). In addition, the available treatment 
processes remove them only partially (Gabet-Giraud et al., 2010; Vieno et al., 
2006; Bendz et al., 2005; Carballa et al., 2004), therefore, they continuously 
enter surface waters. Those that are resistant to natural attenuation processes 
might be accumulated over time and consequently pose a threat to aquatic life 
through chronic exposure. Hence, in this thesis the main focus was to 
contribute to the available knowledge on the source, occurrence, and natural 
attenuation of PPCPs, hormones, and some other environmentally relevant 
contaminants in natural waters. 
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2 Background 
2.1  Sources of Pharmaceuticals and Other Organic Pollutants in 
Rivers 
PPCPs, hormones, and pesticides are introduced to aquatic environments 
continuously or occasionally via a number of point and non-point routes. 
Discharges of treated wastewaters have been identified to be major point 
sources of PPCPs and hormones in the environment (Gabet-Giraud et al., 2010; 
Vieno et al., 2007a). Production facilities can also be important local point 
sources of PPCPs and hormones in adjacent surface waters (Zuccato et al., 
2000), especially in middle-income countries such as China and India where 
strict regulations on discharge of drugs into the environment are not in place 
(Larsson et al., 2007). Furthermore, urban and agricultural runoff, leakage 
from septic tanks, recreational activities, and combined sewer overflows 
(CSOs) during storm events or system failure tanks can occasionally become 
potential sources of PPCPs and hormones in natural waters (Benotti et al., 
2009; Godfrey et al., 2007; Metcalfe et al., 2003a). 
Concentrations of pesticides in raw sewage mostly reflect the 
concentrations in drinking water and urban surface runoff in CSOs (Nitschke & 
Schüssler, 1998). However, concentrations of pesticides in surface waters 
reflect recent and cumulative concentrations from agricultural runoff as well as 
in-stream elimination processes (Hua et al., 2006b; Albanis et al., 1998; 
Nitschke & Schüssler, 1998) 
2.2  Occurrence of Pharmaceuticals and Other Organic 
Pollutants in Treated Wastewaters and Rivers 
In the last fifteen years several studies have demonstrated the presence of 
PPCPs, hormones, and pesticides in different water compartments. Presently, 16 
data in about 150 peer-reviewed papers, covering different geographical 
regions with focus on industrialized countries from the northern hemisphere, 
are summarized in Table 1. 
2.2.1 Treated  Wastewater 
Most of the presented data in Table 1 are based on studies conducted in Europe 
(61% for PPCPs, 58% for hormones, and 90% for pesticides), followed by 
North America (27% for PPCPs, 29% for hormones, and 10% for pesticides), 
and Asia (12% for PPCPs, 13% for hormones, while no data was found for 
pesticides). Among the thirteen PPCPs, highest concentrations in Europe were 
reported for ibuprofen (48240 ng L
-1) and caffeine (44000 ng L
-1) in Spain. The 
highest values for North America and Asia were reported for naproxen in 
Canada (34000 ng L
-1) and caffeine in Japan (3500 ng L
-1), respectively.   
Concentrations of estradiol, estrone, and progesterone were lower than PPCPs 
and in all the three regions. Estrone was found at the highest concentration of 
these three compounds, i.e. 82 ng L
-1 in Italy, 96 ng L
-1 in Canada, and 110 ng 
L
-1 in Japan. Of the five pesticides the highest concentration was observed for 
simazine in Switzerland (200 ng L
-1).  
Differences in concentrations of treated wastewaters between different 
compounds and countries generally reflect different usage patterns, per-capita 
water consumption, and treatment processes. 
2.2.2 River 
Most of the collected information in Table 1 corresponds to the available data 
from Europe (68% of PPCPs, 59% of hormones, and 65% of pesticides) 
followed by North America (13% of PPCPs, 12% of hormones, and 25% of 
pesticides), and Asia (19% of PPCPs, 29% of hormones, and 10% of 
pesticides). In Europe, the highest concentrations of PPCPs, hormones, and 
pesticides were 43500 ng L
-1 for caffeine, 81 ng L
-1 for estrone, and 2218 ng L
-1 
for simazine, respectively.  In North America, the highest values for PPCPs, 
hormones, and pesticides were 6000 ng L
-1  for caffeine, 200 ng L
-1  for 
estradiol, and 9840 ng L
-1 for atrazine, respectively. In Asia, the highest values 
for PPCPs, hormones, and pesticides were 6000 ng L
-1 for caffeine, 65 ng L
-1 
for estrone, and 780 ng L
-1 for atrazine, respectively.  
More than 96% of the presented data from treated waste- and surface waters 
belong to high-income countries where industrial discharges are supposed to be 
controlled, e.g. Good Manufacturing Practices and emission regulations in the 
United States (Velagaleti et al., 2002). In contrast, only a few data are available 
from low- to middle-income countries where several manufacturing facilities 
are located and less strict regulations are applied, e.g. China and India. The 17 
latter combined with a large variation in the concentrations of the studied 
compounds within and between countries indicate that the results from one 
region are not necessarily applicable to other regions.  
Table 1. Occurrence of the studied compounds (ng L
-1) in treated wastewaters and rivers in 
different countries around the world. 
  Sampling location  Treated wastewaters  Rivers  Reference 
IBU Austria  20-2400    (Clara et al., 2005) 
 Canada  140-6300    (Comeau  et al., 2008) 
 Canada    143Mean (Yu  et al., 2007) 
 Canada  381-1191    (Gagné  et al., 2006) 
 Canada  773Max   (Lishman  et al., 2006) 
 Canada  2235-6718    (Verenitch  et al., 2006) 
 Canada  110-2170    (Lee  et al., 2005) 
 Canada  25000Max   (Metcalfe  et al., 2003a) 
 Canada  1885Mean 790Max (Metcalfe  et al., 2003b) 
 China    1417Max (Peng  et al., 2008) 
 Croatia  40-800    (Gros  et al., 2006) 
 Europe
1 20-7110   (Andreozzi  et al., 2003) 
 Europe
II 18-1860  60-152  (Hernando  et al., 2006) 
 Europe 
III   31323Max (Loos  et al., 2009) 
 Finland    12-69  (Vieno et al., 2007b) 
 Finland    2-64  (Lindqvist  et al., 2005) 
 France  18-219    (Rabiet  et al., 2006) 
 Germany    <2-70  (Wiegel  et al., 2004) 
 Germany  130Mean   (Ternes  et al., 2003) 
 Germany  3400Max 530Max (Ternes,  1998) 
 Italy    1.3-73  (Loos  et al., 2007) 
 Italy  121Median 20Median (Zuccato  et al., 2005) 
 Italy    4.5-78.5  (Calamari  et al., 2003) 
 Japan  40Mean   (Kimura  et al., 2007) 
 Japan  1.4-67    (Nakada  et al., 2006) 
 Romania    61-115  (Moldovan,  2006) 
 South  Korea    1-51  (Yoon  et al., 2010) 
 South  Korea    ND-414 (Kim  et al., 2009) 
 South  Korea  10-137  11-38  (Kim  et al., 2007) 
 Spain    6-2784  (Fernández  et al., 2010) 
 Spain  240-28000    (Gomez  et al., 2007) 
  Spain 20-690  14-44 (Pedrouzo  et al., 2007) 
 Spain  780-48240    (Santos  et al., 2007) 18 
  Sampling location  Treated wastewaters  Rivers  Reference 
 Spain  42-10639    (Martinez  Bueno  et al., 2007) 
 Spain    150Max (Gros  et al., 2006) 
 Spain/Croatia  <150-1050    (Petrovic  et al., 2006) 
 Spain  10100Max   (Santos  et al., 2005) 
 Spain  910-2100    (Carballa  et al., 2004) 
 Sweden  150Mean 10-220 (Bendz  et al., 2005) 
 Switzerland  5-1500  80Max (Ollers  et al., 2001) 
 Switzerland  2-81    (Buser  et al., 1999) 
 Taiwan  <12-34  <12-30  (Chen  et al., 2008) 
 Taiwan  30Mean   (Lin  et al., 2005) 
 UK  65-491  <0.3-74  (Kasprzyk-Hordern et al., 
2009b) 
 UK    0.6-37  (Kasprzyk-Hordern et al., 
2008) 
 UK  27256Max 5044Max (Ashton  et al., 2004) 
 USA  250 Mean   (Yu  et al., 2006) 
 USA    1000Max (Kolpin  et al., 2002) 
NAP Canada  210-6900    (Comeau  et al., 2008) 
 Canada    83Mean (Yu  et al., 2007) 
 Canada  217-325    (Gagné  et al., 2006) 
 Canada  1189Max   (Lishman  et al., 2006) 
 Canada  633-7962    (Verenitch  et al., 2006) 
 Canada  360-2540    (Lee  et al., 2005) 
 Canada  34000Max   (Metcalfe  et al., 2003a) 
 Canada  524Mean 551Max (Metcalfe  et al., 2003b) 
 China    328Max (Peng  et al., 2008) 
 Croatia  160Max   (Gros  et al., 2006) 
 Europe
1 290-5220    (Andreozzi  et al., 2003) 
 Europe
II 625Max 70Max (Hernando  et al., 2006) 
 Europe 
III   2027Max (Loos  et al., 2009) 
 Finland    13-32  (Vieno et al., 2007b) 
 France  42-289    (Rabiet  et al., 2006) 
 Germany  261Mean    (Quintana & Reemtsma, 2004) 
 Germany  100Mean   (Ternes  et al., 2003) 
 Germany  80Mean   (Heberer,  2002) 
 Germany  520Max 390Max (Ternes,  1998) 
 Japan  99Mean   (Kimura  et al., 2007) 
 Japan  12-139    (Nakada  et al., 2006) 
 Slovenia    17-313  (Kosjek  et al., 2005) 19 
  Sampling location  Treated wastewaters  Rivers  Reference 
 South  Korea    5-100  (Yoon  et al., 2010) 
 South  Korea  20-483  1.8-18  (Kim  et al., 2007) 
  Spain   2-640 (Fernández  et al., 2010) 
 Spain  359-4200    (Martinez  Bueno  et al., 2007) 
 Spain  20-450    (Pedrouzo  et al., 2007) 
 Spain  220-4280    (Santos  et al., 2007) 
 Spain    50Max (Gros  et al., 2006) 
 Spain  3120Max   (Santos  et al., 2005) 
 Spain  800-2600    (Carballa  et al., 2004) 
 Sweden  250Mean 90-250 (Bendz  et al., 2005) 
 Switzerland  100-3500  10-400  (Ollers  et al., 2001) 
 Taiwan  170Mean 30Mean (Lin  et al., 2005) 
 UK  <2-703  <0.3-146  (Kasprzyk-Hordern et al., 
2009b) 
 UK    3-34  (Kasprzyk-Hordern et al., 
2008) 
 USA  <1Mean    (Vanderford & Snyder, 2006) 
 USA  380Mean   (Yu  et al., 2006) 
 USA  81-106    (Boyd  et al., 2003) 
KET Canada  18-120    (Comeau  et al., 2008) 
 Canada  210Max   (Lishman  et al., 2006) 
 Canada  8-351    (Verenitch  et al., 2006) 
 Canada  40-90    (Lee  et al., 2005) 
 Croatia  130-620    (Gros  et al., 2006) 
 Europe
1 1620Max   (Andreozzi  et al., 2003) 
 Europe 
III   239Max (Loos  et al., 2009) 
 Finland    8-28  (Vieno et al., 2007b) 
 Finland    6.5-39  (Lindqvist  et al., 2005) 
 France  22-1081    (Rabiet  et al., 2006) 
 Germany  146Mean    (Quintana & Reemtsma, 2004) 
 Germany  380Max 120Max (Ternes,  1998) 
 Japan  445Mean   (Kimura  et al., 2007) 
 Japan  820Max 24Max (Nakada  et al., 2007) 
 Japan  68-204    (Nakada  et al., 2006) 
 Spain    0.3-991  (Fernández  et al., 2010) 
 Spain  225-954    (Martinez  Bueno  et al., 2007) 
 Spain  550-1500    (Santos  et al., 2007) 
 Spain/Croatia  200-750    (Petrovic  et al., 2006) 
 Spain  1760Max   (Santos  et al., 2005) 20 
    Sampling location  Treated wastewaters  Rivers  Reference 
 Sweden  330Mean 10-70  (Bendz  et al., 2005) 
 Switzerland  200Max 5 Max (Ollers  et al., 2001) 
 Taiwan  330-700  110-620  (Chen  et al., 2008) 
 UK  <3-37  <0.5-12  (Kasprzyk-Hordern et al., 
2009b) 
 UK    6Max  (Kasprzyk-Hordern et al., 
2008) 
 USA  280Mean   (Yu  et al., 2006) 
DIC Austria  780-3464    (Clara  et al., 2005) 
 Austria    16-36  (Ahrer  et al., 2001) 
 Canada  25-190    (Comeau  et al., 2008) 
 Canada    13Mean (Yu  et al., 2007) 
 Canada  748Max   (Lishman  et al., 2006) 
 Canada  32-457    (Verenitch  et al., 2006) 
 Canada  359Mean 50Mean (Metcalfe  et al., 2003b) 
 Croatia  390Max   (Gros  et al., 2006) 
 Europe
II 32-1420  26-72  (Hernando  et al., 2006) 
 Europe 
III   247Max (Loos  et al., 2009) 
 Europe
IV 250-5450   (Ferrari  et al., 2003) 
 Finland    10-55  (Vieno et al., 2007b) 
 Finland    2-40  (Lindqvist  et al., 2005) 
 France  211-486  1.4-1.7  (Rabiet  et al., 2006) 
 Germany  3900Max   (Stülten  et al., 2008) 
 Germany  1561Mean    (Quintana & Reemtsma, 2004) 
 Germany    <1-40  (Wiegel  et al., 2004) 
 Germany  1300Mean   (Ternes  et al., 2003) 
 Germany  2510Mean   (Heberer,  2002) 
 Germany  2100Max 1200Max (Ternes,  1998) 
 Greece  30-120    (Botitsi  et al., 2007) 
 Ireland  <740-<2500    (Lacey  et al., 2008) 
 Italy    1.7-158  (Loos  et al., 2007) 
 Japan  145Mean   (Kimura  et al., 2007) 
 Japan  220Max 3.3Max (Nakada  et al., 2007) 
 Slovenia    9-282  (Kosjek  et al., 2005) 
 South  Korea    1-30  (Yoon  et al., 2010) 
 South  Korea  8.8-127  1.1-6.8  (Kim  et al., 2007) 
 Spain    0.7-156  (Fernández  et al., 2010) 
 Spain  140-2200    (Gomez  et al., 2007) 
 Spain  10-460  25-41  (Pedrouzo  et al., 2007) 21 
  Sampling location  Treated wastewaters  Rivers  Reference 
 Spain  6-5922    (Martinez  Bueno  et al., 2007) 
 Spain    60Max (Gros  et al., 2006) 
 Spain/Croatia  <50-500    (Petrovic  et al., 2006) 
 Sweden  120Mean 10-120 (Bendz  et al., 2005) 
 Switzerland  100-700  20-150  (Ollers  et al., 2001) 
 Switzerland  310-930  11-310  (Buser  et al., 1998) 
 Taiwan  <2-30  24-62  (Chen  et al., 2008) 
 UK  6-496  <0.5-261  (Kasprzyk-Hordern et al., 
2009b) 
 UK  37-176    (Zhou  et al., 2009) 
 UK    12Max  (Kasprzyk-Hordern et al., 
2008) 
 UK  68Mean  3-15  (Zhang & Zhou, 2007) 
 UK  2349Max 568Max (Ashton  et al., 2004) 
 USA  8-177  32Max  (Spongberg & Witter, 2008) 
 USA  <0.5Mean    (Vanderford & Snyder, 2006) 
 USA  90Mean   (Yu  et al., 2006) 
BEZ Austria  73-4800    (Clara  et al., 2005) 
 Austria    2-13  (Ahrer  et al., 2001) 
 Canada  29-260    (Comeau  et al., 2008) 
 Canada  68-72    (Gagné  et al., 2006) 
 Canada  600Max   (Metcalfe  et al., 2003a) 
 Canada  259Mean 200Max (Metcalfe  et al., 2003b) 
 Croatia  10Max   (Gros  et al., 2006) 
 Europe 
III   1235Max (Loos  et al., 2009) 
 Finland    3-20  (Vieno et al., 2007b) 
 Finland    3-24  (Lindqvist  et al., 2005) 
 Germany  565Mean    (Quintana & Reemtsma, 2004) 
 Germany    <50-70  (Wiegel  et al., 2004) 
 Germany  4600Max 3100Max (Ternes,  1998) 
 Italy    0.3-38  (Loos  et al., 2007) 
 Italy  0.3-117    (Castiglioni  et al., 2005) 
 Italy  55Median 57Median (Zuccato  et al., 2005) 
 Italy    0.8-57  (Calamari  et al., 2003) 
 Japan  1500Max 77Max (Nakada  et al., 2007) 
 Spain    0.3-46  (Fernández  et al., 2010) 
 Spain  70-340  16-363  (Pedrouzo  et al., 2007) 
 Spain  61-484    (Martinez  Bueno  et al., 2007) 
 Spain    10Max (Gros  et al., 2006) 22 
  Sampling location  Treated wastewaters  Rivers  Reference 
 UK  <85-667  <10-90  (Kasprzyk-Hordern et al., 
2009b) 
GEM Canada  6-710    (Comeau  et al., 2008) 
 Canada  59-84    (Gagné  et al., 2006) 
 Canada  436Max   (Lishman  et al., 2006) 
 Canada  80-478    (Verenitch  et al., 2006) 
 Canada  80-2090    (Lee  et al., 2005) 
 Canada  1300Max   (Metcalfe  et al., 2003a) 
 Canada  1493Mean 112Max (Metcalfe  et al., 2003b) 
 Croatia  320Max   (Gros  et al., 2006) 
 Europe
1 60-4760   (Andreozzi  et al., 2003) 
 Europe 
III   970Max (Loos  et al., 2009) 
 France  13-17    (Rabiet  et al., 2006) 
 Germany    <2-8  (Wiegel  et al., 2004) 
 Germany  70Mean   (Heberer,  2002) 
 Germany  1500Max 510Max (Ternes,  1998) 
 Ireland  <32-330    (Lacey  et al., 2008) 
 Italy    0.4-44  (Loos  et al., 2007) 
 South  Korea    0.25-13  (Yoon  et al., 2010) 
 South  Korea  3.9-17  1.8-9.1  (Kim  et al., 2007) 
 Spain  2-28571    (Martinez  Bueno  et al., 2007) 
 Spain    60Max (Gros  et al., 2006) 
 Sweden  180Mean 170Max (Bendz  et al., 2005) 
 USA  42-84  6Max  (Spongberg & Witter, 2008) 
 USA  9Mean    (Vanderford & Snyder, 2006) 
 USA  130Mean   (Yu  et al., 2006) 
 USA    790Max (Kolpin  et al., 2002) 
ATE Canada  642-1680    (Lee  et al., 2007) 
 Croatia  1150Max   (Gros  et al., 2006) 
 Finalnd    17-55  (Vieno et al., 2007b) 
 Finland  40-1180    (Vieno et al., 2007a) 
 Finland  40-440  <12-25  (Vieno  et al., 2006) 
 France  36-2257    (Gabet-Giraud  et al., 2010) 
 Germany  360Mean   (Ternes  et al., 2003) 
 Italy  27-1168    (Castiglioni  et al., 2005) 
 Italy  466Median 241Median (Zuccato  et al., 2005) 
 Italy    3.4-241  (Calamari  et al., 2003) 
 Japan  930Max 46Max (Nakada  et al., 2007) 
 South  Korea    2-150  (Yoon  et al., 2010) 23 
  Sampling location  Treated wastewaters  Rivers  Reference 
 South  Korea    ND-690 (Kim  et al., 2009) 
 Spain    2-334  (Fernández  et al., 2010) 
 Spain  66-9929    (Huerta-Fontela  et al., 2010) 
 Spain  618-1370    (Gros  et al., 2008) 
 Spain  275-4850    (Martinez  Bueno  et al., 2007) 
 Spain/Croatia  <50-1200    (Petrovic  et al., 2006) 
 Sweden  160Mean 10-60  (Bendz  et al., 2005) 
 Switzerland  404-678    (Maurer  et al., 2007) 
 UK  1260-7606  <1-560  (Kasprzyk-Hordern et al., 
2009b) 
 UK    3-60  (Kasprzyk-Hordern et al., 
2007) 
 USA  879Mean    (Vanderford & Snyder, 2006) 
MET Canada  177-402    (Lee  et al., 2007) 
 Europe
1 10-390    (Andreozzi  et al., 2003) 
 Finland    39-107  (Vieno et al., 2007b) 
 Finland  280-1600    (Vieno et al., 2007a) 
 Finland  910-1070  <4-116  (Vieno  et al., 2006) 
 France  16-435    (Gabet-Giraud  et al., 2010) 
 Germany  1700Mean   (Ternes  et al., 2003) 
 Germany  2200Max 2200Max (Ternes,  1998) 
 Japan  23Max   (Nakada  et al., 2007) 
 Poland    51-155  (Kasprzyk-Hordern et al., 
2007) 
 Spain    2-26  (Fernández  et al., 2010) 
 Spain  113-407    (Huerta-Fontela  et al., 2010) 
 Spain  79-547    (Gros  et al., 2008) 
 Spain  18-154    (Martinez  Bueno  et al., 2007) 
 Spain  20-140    (Pedrouzo  et al., 2007) 
 Sweden  190Mean 70Max (Bendz  et al., 2005) 
 Switzerland  103-161    (Maurer  et al., 2007) 
 UK  34-130  <0.5-12  (Kasprzyk-Hordern et al., 
2009b) 
 UK    8Max  (Kasprzyk-Hordern et al., 
2007) 
 USA  1200Max   (Huggett  et al., 2003) 
SOT Canada  162-429    (Lee  et al., 2007) 
 Croatia  210Max   (Gros et al., 2006) 
 Finland    30-86  (Vieno et al., 2007b) 
 Finland  130-1120    (Vieno et al., 2007a) 24 
  Sampling location  Treated wastewaters  Rivers  Reference 
 Finland  160-300  <4-52  (Vieno  et al., 2006) 
 France  128-3334    (Gabet-Giraud  et al., 2010) 
 Germany  1320Mean   (Ternes  et al., 2003) 
 Spain  11-168    (Huerta-Fontela  et al., 2010) 
 Spain  230-308    (Gros  et al., 2008) 
 Spain  12-155    (Martinez  Bueno  et al., 2007) 
 Switzerland  251Max   (Maurer  et al., 2007) 
ACE Canada  184-662    (Lee  et al., 2007) 
 Europe
1 <10-130   (Andreozzi  et al., 2003) 
 Finland    3-14  (Vieno et al., 2007b) 
 Finland  35-255    (Vieno et al., 2007a) 
 Finland  80-230  <1-8  (Vieno  et al., 2006) 
 France  32-3648    (Gabet-Giraud  et al., 2010) 
 Spain  4-50    (Huerta-Fontela  et al., 2010) 
 Taiwan    10-17  (Lin  et al., 2010) 
CBZ Austria  465-1619    (Clara  et al., 2005) 
 Austria    23-133  (Ahrer  et al., 2001) 
 Canada    99Mean (Yu  et al., 2007) 
 Canada  33-137    (Gagné  et al., 2006) 
 Canada  251Mean   (Miao  et al., 2005) 
 Canada  2300Max   (Metcalfe  et al., 2003a) 
 Canada  126Mean 650Max (Metcalfe  et al., 2003b) 
 Canada  426Mean 0.7Mean  (Miao & Metcalfe, 2003) 
 Europe
1 300-1200    (Andreozzi  et al., 2003) 
 Europe 
III   11561Max (Loos  et al., 2009) 
 Europe
IV 300-1200   (Ferrari  et al., 2003) 
 Finland    21-80  (Vieno et al., 2007b) 
 Finland  290-2440    (Vieno et al., 2007a) 
 Finland  380-470  <1.5-66  (Vieno  et al., 2006) 
 France  157-293    (Rabiet  et al., 2006) 
 Germany  1900Max 81Max (Hummel  et al., 2006) 
 Germany    <30-70  (Wiegel  et al., 2004) 
 Germany  2100Mean   (Ternes  et al., 2003) 
 Germany  1630Mean   (Heberer,  2002) 
 Germany  6300Max 1100Max (Ternes,  1998) 
 Ireland  160-880    (Lacey  et al., 2008) 
 Italy    7-345  (Loos  et al., 2007) 
 Italy  33-1318    (Castiglioni  et al., 2005) 
 Italy  291Median 175Median (Zuccato  et al., 2005) 25 
  Sampling location  Treated wastewaters  Rivers  Reference 
 Japan  86Max 12Max (Nakada  et al., 2007) 
 Japan  11-149    (Nakada  et al., 2006) 
 Korea  <5-195  <5-36  (Choi  et al., 2008) 
 Poland    311-794  (Kasprzyk-Hordern et al., 
2007) 
 Romania    65-75  (Moldovan,  2006) 
 South  Korea    8-68  (Yoon  et al., 2010) 
 South  Korea    ND-595 (Kim  et al., 2009) 
 South  Korea  73-729  4.5-61  (Kim  et al., 2007) 
 Spain    0.3-104  (Fernández  et al., 2010) 
 Spain  5-175    (Huerta-Fontela  et al., 2010) 
 Spain  110-230    (Gomez  et al., 2007) 
 Spain  69-273    (Martinez  Bueno  et al., 2007) 
 Spain  80-290  9-37  (Pedrouzo  et al., 2007) 
 Spain  120-1290    (Santos  et al., 2007) 
 Spain/Croatia  <100-600    (Petrovic  et al., 2006) 
 Spain  750Max   (Santos  et al., 2005) 
 Sweden  1180Mean 500Max (Bendz  et al., 2005) 
 Switzerland  100-800  30-250  (Ollers  et al., 2001) 
 Taiwan  290-960  <0.5-120  (Chen  et al., 2008) 
 Taiwan  420Mean   (Lin  et al., 2005) 
 UK  152-4596  <0.5-647  (Kasprzyk-Hordern et al., 
2009b) 
 UK  233-1061    (Zhou  et al., 2009) 
 UK    9Max  (Kasprzyk-Hordern et al., 
2007) 
 UK  652Mean  20-140  (Zhang & Zhou, 2007) 
  USA  188-207    (Guo & Krasner, 2009) 
 USA  34-111  14Max  (Spongberg & Witter, 2008) 
 USA    6Max (Conley  et al., 2008) 
 USA  187Mean    (Vanderford & Snyder, 2006) 
 USA  270Max 186Max (Glassmeyer  et al., 2005) 
 USA    2-263  (Kolpin  et al., 2004) 
CAF Canada  320-2100    (Comeau  et al., 2008) 
 Canada  315-22000    (Gagné  et al., 2006) 
 Canada  1742-8132    (Verenitch  et al., 2006) 
 Canada  677Mean 46Mean (Metcalfe  et al., 2003b) 
 Europe 
III   39813Max (Loos  et al., 2009) 
 France  255-2213    (Rabiet  et al., 2006) 26 
  Sampling location  Treated wastewaters  Rivers  Reference 
 Germany  220Mean   (Ternes  et al., 2003) 
 Germany  180Mean   (Heberer,  2002) 
 Italy    0.6-1056  (Loos  et al., 2007) 
 Japan  3500Max 2100Max (Nakada  et al., 2007) 
 Korea  19-873  <10-373  (Choi  et al., 2008) 
 Romania    428-9700  (Moldovan,  2006) 
 South  Korea    38-250  (Yoon  et al., 2010) 
 South  Korea  23-776  2.9-194  (Kim  et al., 2007) 
 Spain    12-416  (Fernández  et al., 2010) 
 Spain  30-43500    (Huerta-Fontela  et al., 2008) 
 Spain  1400-44000   (Gomez  et al., 2007) 
 Spain  20-1010  106-305  (Pedrouzo  et al., 2007) 
 Spain  150-3200    (Santos  et al., 2007) 
 Spain  262-24658    (Martinez  Bueno  et al., 2007) 
 Spain  4520Max   (Santos  et al., 2005) 
 Sweden  220Mean 110Max (Bendz  et al., 2005) 
 Switzerland  30-9500  26-250  (Buerge  et al., 2003) 
 Taiwan    3500-6000 (Lin  et al., 2010) 
  USA  48-202    (Guo & Krasner, 2009) 
  USA  4-23  27-320  (Spongberg & Witter, 2008) 
 USA    23-39  (Conley  et al., 2008) 
 USA  190-9900    (Batt  et al., 2006) 
 USA  7990Max 2600Max (Glassmeyer  et al., 2005) 
 USA    36-1390  (Kolpin  et al., 2004) 
 USA    6000Max (Kolpin  et al., 2002) 
TRI Canada  100Mean   (Segura  et al., 2007) 
 Canada  60-70    (Gagné  et al., 2006) 
 Canada  194Mean   (Metcalfe  et al., 2003b) 
 Croatia  70-310    (Gros  et al., 2006) 
 Europe
1 20-130    (Andreozzi  et al., 2003) 
 France    45Max (Tamtam  et al., 2008) 
 Germany    <30-30  (Wiegel  et al., 2004) 
 Germany  340Mean   (Ternes  et al., 2003) 
 Germany  660Max 200Max (Hirsch  et al., 1999) 
 Greece  12-300    (Botitsi  et al., 2007) 
 Hong  Kong    2-22  (Gulkowska  et al., 2007) 
 Ireland  <70-360    (Lacey  et al., 2008) 
 Japan  56Max   (Nakada  et al., 2007) 
 Korea  <10-174  <10-26  (Choi  et al., 2008) 27 
  Sampling location  Treated wastewaters  Rivers  Reference 
 Poland    8-27  (Kasprzyk-Hordern et al., 
2007) 
 South  Korea    1-17  (Yoon  et al., 2010) 
 South  Korea  10-188  3.2-5.3  (Kim  et al., 2007) 
 Spain    0.4-23  (Fernández  et al., 2010) 
 Spain  99-1264    (Martinez  Bueno  et al., 2007) 
 Spain/Croatia  <5-230    (Petrovic  et al., 2006) 
 Sweden  613-1880    (Lindberg  et al., 2006) 
 Sweden  40Mean 20Max (Bendz  et al., 2005) 
 Sweden  66-1340    (Lindberg  et al., 2005) 
 UK  385-3052  <0.5-183  (Kasprzyk-Hordern et al., 
2009b) 
 UK  1288Max 42Max (Ashton  et al., 2004) 
 USA    7Max (Conley  et al., 2008) 
 USA  90-530    (Batt  et al., 2006) 
 USA  550Max    (Karthikeyan & Meyer, 2006) 
 USA  <0.5Mean    (Vanderford & Snyder, 2006) 
 USA  353Max   414Max (Glassmeyer  et al., 2005) 
 USA    80Max (Kolpin  et al., 2004) 
 USA    710Max (Kolpin  et al., 2002) 
 Vietnam    7-44  (Managaki  et al., 2007) 
ATR Belgium  78Mean 65Mean (Benijts  et al., 2004) 
 Canada    7-79  (Hua et al., 2006a) 
  Canada    46-52  (Sabik & Jeannot, 1998) 
 China    57-780  (Ma  et al., 2003a) 
 Europe 
III   46Max (Loos  et al., 2009) 
 Greece    310Max (Albanis  et al., 1998) 
 Hong  Kong    10Mean (Ma  et al., 2003b) 
 Italy    3.2Max (Loos  et al., 2007) 
 Italy    3.5-7  (Di  Corcia  et al., 1997) 
  Netherlands   510Mean (Steen  et al., 1999) 
 South  Korea    <0.25-1  (Yoon  et al., 2010) 
 Spain  9Mean   (Martinez  Bueno  et al., 2007) 
 Spain    2-1793  (Planas  et al., 2006) 
 Spain    5-463  (Rodriguez-Mozaz  et al., 2004) 
 Spain    120-170  (Carabias-Martínez et al., 
2002) 
 Switzerland  10-90  10-80  (Ollers  et al., 2001) 
 Switzerland    75Mean (Berg  et al., 1995) 28 
  Sampling location  Treated wastewaters  Rivers  Reference 
 USA  0.8Mean    (Vanderford & Snyder, 2006) 
 USA    <50-9840  (Rebich  et al., 2004) 
DEA Belgium  16Mean 34Mean (Benijts  et al., 2004) 
  Canada    24-36  (Sabik & Jeannot, 1998) 
 China    652Mean (Ma  et al., 2003a) 
 Greece    526Max (Albanis  et al., 1998) 
 Italy    4-6.5  (Di  Corcia  et al., 1997) 
  Netherlands   19Mean (Steen  et al., 1999) 
 Spain    8-874  (Planas  et al., 2006) 
 Spain    4Max (Rodriguez-Mozaz  et al., 2004) 
 Spain    300Mean  (Carabias-Martínez et al., 
2002) 
 Switzerland    198Mean (Berg  et al., 1995) 
 USA    <50-1070  (Rebich  et al., 2004) 
DIA Belgium  12Mean   (Benijts  et al., 2004) 
  Canada    3-11  (Sabik & Jeannot, 1998) 
 Italy    2-5  (Di  Corcia  et al., 1997) 
  Netherlands   6Mean (Steen  et al., 1999) 
 Spain    10-802  (Planas  et al., 2006) 
 Switzerland    41Mean (Berg  et al., 1995) 
 USA    <50-560  (Rebich  et al., 2004) 
CYA Belgium  76Mean   (Benijts  et al., 2004) 
  Canada    3-10  (Sabik & Jeannot, 1998) 
 USA    <50-810  (Rebich  et al., 2004) 
SIM Belgium  35Mean 57Mean (Benijts  et al., 2004) 
  Canada    6-9  (Sabik & Jeannot, 1998) 
 Europe 
III   169Max (Loos  et al., 2009) 
 Greece    317Max (Albanis  et al., 1998) 
 Italy    8.5Max (Loos  et al., 2007) 
 Spain  9-28    (Martinez  Bueno  et al., 2007) 
 Spain    2-605  (Planas  et al., 2006) 
 Spain    8-2218  (Rodriguez-Mozaz  et al., 2004) 
 Switzerland  20-200  10-100  (Ollers  et al., 2001) 
 Switzerland  93Mean 36Mean (Berg  et al., 1995) 
 USA    <50-610  (Rebich  et al., 2004) 
PRO USA    199Max (Kolpin  et al., 2002) 
 South  Korea    <0.5Max (Yoon  et al., 2010) 
ESD Austria  3-30    (Clara  et al., 2005) 
 Canada  <1-2    (Lee  et al., 2005) 29 
  Sampling location  Treated wastewaters  Rivers  Reference 
 Canada  0.2-14.7    (Servos  et al., 2005) 
 Canada  64Max   (Ternes  et al., 1999) 
 China    2Max (Peng  et al., 2008) 
 France  1-11    (Gabet-Giraud  et al., 2010) 
  Germany  0.15-5  0.15-4  (Kuch & Ballschmiter, 2001) 
 Germany  3Max   (Ternes  et al., 1999) 
 Italy    0.9Max (Loos  et al., 2007) 
 Italy  0.35-3.5    (Baronti  et al., 2000) 
 Japan  0.5-17    (Nakada  et al., 2006) 
  Netherlands 12Max 5.5Max (Belfroid  et al., 1999) 
 South  Korea    <0.5  (Yoon  et al., 2010) 
 South  Korea  <1    (Kim  et al., 2007) 
 UK  0.7Mean   (Koh  et al., 2007) 
 UK  3-48    (Desbrow  et al., 1998) 
 USA    200Max (Kolpin  et al., 2002) 
 USA  <0.5-4    (Snyder  et al., 1999) 
ESN Austria  2-72    (Clara  et al., 2005) 
 Belgium    22  (Benijts  et al., 2004) 
 Canada    88Mean (Yu  et al., 2007) 
 Canada  38Max   (Lishman  et al., 2006) 
 Canada  <1-54    (Lee  et al., 2005) 
 Canada  1-96    (Servos  et al., 2005) 
 Canada  48Max   (Ternes  et al., 1999) 
 China    65Max (Peng  et al., 2008) 
 Europe 
III   81Max (Loos  et al., 2009) 
 France  0.2-65    (Gabet-Giraud  et al., 2010) 
 Germany  15Mean   (Ternes  et al., 2003) 
  Germany  0.35-18  0.1-4  (Kuch & Ballschmiter, 2001) 
 Germany  70Max 1.6Max (Ternes  et al., 1999) 
 Italy    2.0Max (Loos  et al., 2007) 
 Italy  30-48    (Castiglioni  et al., 2005) 
 Italy  2.5-82    (Baronti  et al., 2000) 
 Japan  3-110    (Nakada  et al., 2006) 
  Netherlands 47Max 3.4Max (Belfroid  et al., 1999) 
 South  Korea    0.2-4  (Yoon  et al., 2010) 
 South  Korea  2.2-36  1.7-5  (Kim  et al., 2007) 
 Spain    4-22  (Rodriguez-Mozaz  et al., 2004) 
 UK  3Mean   (Koh  et al., 2007) 
 UK  1.4-76    (Desbrow  et al., 1998) 30 
  Sampling location  Treated wastewaters  Rivers  Reference 
 USA    112Max (Kolpin  et al., 2002) 
1. I for France, Greece, Italy, Sweden. 
2. II for Spain, Belgium, Germany, Slovenia. 
3. III for EU Member States. 
4. IV for France, Greece, Italy, Sweden. 
2.3  Fate of Pharmaceuticals in Rivers 
Upon discharge of treated wastewaters into surface waters, concentrations of 
pharmaceuticals decline, mainly due to dilution to a varying extent being 
dependent upon factors such as stream flow rate conditions and percentage of 
treated wastewaters in the receiving water bodies.  
Depending on chemical structure, environmental condition (e.g. 
temperature, light intensity, sediment type, turbidity, humic substances, 
nitrate), biotic and abiotic processes such as biotransformation, 
phototransformation, and sorption might also decrease concentrations of 
pharmaceuticals in the aquatic environment. For example, biotransformation 
has been highlighted as a potential elimination pathway of ibuprofen and 
naproxen once they have been released into the water column (Fono et al., 
2006; Löffler et al., 2005; Buser et al., 1999). Phototransformation occurs 
either directly by absorption of solar photons or indirectly by energy transfer 
from excited photosensitizers, e.g. nitrate and humic substances. Some 
pharmaceuticals such as diclofenac, naproxen, and ketoprofen have been 
reported to be amenable to direct photolytic reaction, with half-lives of less 
than three hours (Eriksson et al., 2010; Lin et al., 2006; Lin & Reinhard, 2005; 
Poiger et al., 2001; Buser et al., 1998), while ibuprofen was expected to 
undergo indirect phototransformation (Lin & Reinhard, 2005).  It has been 
shown that the presence of humic substances hindered phototransformation of 
diclofenac and carbamazepine while nitrate enhanced the phototransformation 
rate of these compounds (Andreozzi et al., 2003). Despite a positive effect of 
phototransformation in reducing drug levels in the environment, 
phototransformation can lead to the formation of transformation products 
which are more stable and toxic than the parent compounds, e.g. the 
carcinogenic acridine is formed during phototransformation of carbamazepine 
(Chiron et al., 2006). There is also a concern about the enhanced toxicity of 
phototransformation products of diclofenac, e.g. diphenylamines and 
carbazoles as compared to the parent compound (Svanfelt & Kronberg, 2011; 
Schmitt-Jansen et al., 2007). Sorption is mainly dependent on soil and 
sediment characteristics such as particle size and type (Scheytt et al., 2005). 
Octanol-water partitioning coefficient (Kow) is often used to predict ability of a 31 
compound to be sorbed to soil and sediment particles. However, since degree 
of ionization of a compound is pH dependent and only the unionized species 
are partitioned into lipid phase, this approach is appropriate for neutral 
compounds (Vieno, 2007).  
Even though several fate studies have been published during recent years, 
most of the reported data were based on bench scale studies where dynamic 
changes in hydraulic and chemical conditions differ from field studies, 
resulting in inconclusive statements on the attenuation mechanism of 
individual compounds. Lin et al. (2006) reported much shorter half-life time 
for ibuprofen (5.4 h) and naproxen (1.7-3.0 h) in a Californian river compared 
to data by Fono et  al. (2006) in a Texan river (Dissipation half-life for 
ibuprofen 4.6 d and for naproxen 4.2 d). Based on a microcosm experiment, 
biotransformation was insignificant for naproxen (Lin et al., 2006); however, it 
has been marked as a relevant loss mechanism in a Swiss lake (Tixier et al., 
2003) and a Texan river (Fono et al., 2006). For ibuprofen, sedimentation and 
phototransformation were shown to be negligible (Yamamoto et al., 2009; 
Löffler et al., 2005), though, Tixier et al. (2003) argued that sorption of this 
compound, which has a relatively high sorption coefficient (Table 2), could not 
be ruled out.   
2.4  Pharmaceuticals and Personal Care Products as Indicators 
of Fecal Contamination  
Microbial safety of drinking water intakes associated with fecal 
contamination has traditionally been assessed by measuring indicator bacteria 
of water quality, most commonly, thermotolerant coliforms and Escherichia 
coli (Domingo ed., 2005). Bacterial test, however, is a time-consuming 
procedure (Glassmeyer et al., 2005). In addition, indicator bacteria have a short 
survival time and their source specificity, i.e. differentiating between human 
and non-human sources of fecal contamination, is limited (Hagedorn & 
Weisberg, 2009; Glassmeyer et al., 2005; Buerge et al., 2003). Hence, in recent 
years, human-origin chemical markers with the advantage of shorter analysis 
times and being more source-specific have received considerable attention as 
potential alternatives to identify sources of pollution assigned to human 
activity. Nevertheless, application of chemical indicators was recommended 
during initial screening or as cross-validation supplements rather than 
replacement of conventional microbial markers (Hagedorn & Weisberg, 2009). 
Nakada  et  al. (2008) reported crotamiton and carbamazepine as 
conservative indicators of sewage-derived contaminations in Japanese rivers.  
In another study, conducted in 40 sampling sites across the United States 32 
evaluating the potential of 110 human-specific chemicals, caffeine, 
carbamazepine, and diphenhydramine were among the seven best promising 
indicators of human fecal material (Glassmeyer et al., 2005). Caffeine was 
found to be ubiquitous in Swiss rivers and lakes in sufficiently high 
concentrations for reliable analytical quantification and has been proposed as 
an indicator of anthropogenic pollution (Buerge et al., 2003). Recently, Sauvé 
et al. (2012) demonstrated relatively good correlations between fecal coliforms 
and caffeine concentrations in storm water collection systems, and suggested 
caffeine as an indicator of the source of sanitary contamination. It has also 
been suggested that the combination of conservative (e.g. carbamazepine) and 
labile (e.g. caffeine) markers might be beneficial in assessing percentage of 
raw and treated wastewater discharged to aquatic environments (Kasprzyk-
Hordern et al., 2009a; Nakada et al., 2008). 
Although a growing number of publications suggest the use of chemical 
markers for fecal tracking, geographical-temporal assessments appear desirable 
because of variations in usage pattern, consumer habits, water consumption, 
and removal by wastewater treatment (Hagedorn & Weisberg, 2009). 
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3  Objectives of the Thesis 
The main objective of the thesis was to increase knowledge on temporal and 
spatial occurrence and removal of pharmaceuticals in natural surface waters 
that are exposed to continuous and intermittent anthropogenic sources.  The 
specific objectives were: 
 
1.  To monitor the level of pharmaceuticals in WWTP effluents and river 
waters (papers I-V). 
 
2.  To identify continuous and intermittent sources of pharmaceuticals in river 
waters (papers I-V). 
 
3.  To identify suitable chemical indicators of fecal contaminations in river 
waters (paper IV). 
 
4.  To evaluate seasonal variations of pharmaceutical mass flows and their 
respective removal efficiencies in river waters (papers I, II). 
 
5.  To compare removal efficiencies of pharmaceuticals and nutrients in river 
waters (paper V). 
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4 Selected  Compounds 
The main focus of this work was on ten pharmaceuticals spanning a range of 
therapeutic classes, in particular four analgesics, four beta-blockers, one lipid 
regulator, and one antiepileptic, in Sweden.  In addition we analyzed a diverse 
group of compounds, including PPCPs, hormones, and pesticides, in Canada. 
The compounds were selected on the basis of their high consumption in 
Sweden and Canada and availability of reliable analytical methods (Viglino et 
al., 2008a; Viglino et al., 2008b; Vieno et al., 2006; Lindqvist et al., 2005).  
Acebutolol, however, was an exception as it is not consumed in Sweden but 
detected in relatively high concentrations in WWTPs in Finland, a neighboring 
country (Vieno et al., 2006). The target compounds represent different 
physico-chemical properties, e.g. molecular weight (MW) ranging from 173.6 
to 361.8 g mole
-1, acid dissociation constant (Pka) ranging from 0.87 to 10.77, 
and log Kow ranging from -0.07 to 4.77 (Table 2). About 80% of the 
compounds have medium to low affinity for sorption to hydrophobic surfaces, 
i.e. log Kow ≤ 4.0 (Rogers, 1996). However, in our river systems in which pH 
ranges from 7.6 to 8.2 (Papers I, II, IV), the majority of the compounds are 
ionizable; as a result, their Kow might be subject to change. Hence, their degree 
of sorption to natural soil and sediments in aquatic environments should be 
instead evaluated based on sorption distribution coefficient (Kd) values (Table 
2). 
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Table 2. The target compounds and their physico-chemical properties. 
 Use  MW  (g  mol
-1) pKa  log  Kow log  Kd, sediment Paper 
IBU Analgesic  206.3    4.91
1 3.97
1 -0.74-0.23
4 I 
NAP Analgesic  230.3    4.15
1 3.18
1 0.46
6 I,  IV 
KET Analgesic  254.3    4.45
1 3.12
1 0.95
7 I 
DIC Analgesic  296.2    4.15
1 4.51
1 -0.26-0.67
4 I 
BEZ Lipid  regulator  361.8    3.61
2 4.25
1 1.15soil
7 I 
GEM Lipid  regulator  250.3   4.42
3 4.77
3 -0.92-0.96soil
8 IV 
ATE Beta  blocker  266.3    9.60
1 0.16
1 0.11-0.91
9 II 
MET Beta  blocker  267.4   9.60
1 1.88
1 1.30
7 II 
SOT Beta  blocker  272.4    8.30-9.80
2 0.24
1 2.56secondary sludge
10 II 
ACE Beta  blocker  336.4    9.33
1 1.71
1 3.28
11 II 
CBZ Antiepileptic  236.3    14.00
4 2.45
1 -0.68-0.73
4 II,  IV 
CAF Stimulant  194.2    10.40
1 -0.07
1 1.40soil-2.40
7,11 IV 
TRI Anti-infective  290.3    7.12
1 0.91
3 1.4soil
7 IV 
ATR Herbicide  215.7    1.70
1 2.61
1 -0.85-0.15
12 IV 
DEA  ATR & SIM metabolite  187.6    1.40
5 1.51
1 -1.70-(-0.20)soil
5 IV 
DIA Herbicide  173.6    1.50
5 1.15
1 -0.74-0.25soil
5 IV 
CYA Herbicide  240.7   0.87
1 2.22
1   0.22-0.6soil
13 IV 
SIM Herbicide  201.7    1.62
1 2.18
1 -0.89-(-0.39)
14 IV 
PRO Progestogen  314.5    Not Available  3.87
1 2.88-3.04sludge
10 IV 
ESD Estrogen  288.4    10.71
3 4.01
3 -1.28
15 IV 
ESN Estrogen  270.4    10.77
3 3.13
3 -1.39
15 IV 
1. Environment Science SRC PhysProp Database (2012). 
2. Drug Information System (2012). 
3. Li et al., 2011. 
4. Schyett et al., 2005. 
5. Vryzas et al., 2007. 
6. Vieno, 2007. 
7. Barron et al., 2011. 
8. Fang et al., 2012. 
9. Yamamoto et al., 2009. 
10. Hörsing et al., 2011. 
11. Lin et al., 2010. 
12. Schwab et al., 2006. 
13. Schraer et al., 2003. 
14. Daniels et al., 1998. 
15. Cunha et al., 2012. 37 
5 Study  Sites 
In this thesis, most of the reported data are based on samples collected in River 
Fyris in Sweden and Mille-Iles (MI), Des Prairies (DP), L’Assomption (AS), 
and St. Lawrence (SL) rivers in Canada. Both water systems are described in 
detail below. 
5.1 Uppsala,  Sweden 
Sample collections were mainly conducted in River Fyris (59°47'N, 17°39'E), a 
relatively small river which passes through the city of Uppsala in central 
Sweden and merges into Lake Mälaren (59°30'N, 17°12'E), Sweden’s third 
largest lake. The river has a catchment area of 2,006 km
2 consisting of 65% 
forest and 25% agricultural land, with a mean water flow rate of 13 m
3 s
-1, and 
mean annual precipitation of 1.7 mm. A few water samples were also taken 
from Lake Mälaren. The reason for studying River Fyris was the fact that after 
receiving large amounts of treated wastewaters, it merges into Lake Mälaren, 
which is the source water for drinking water productions in the Stockholm 
area. Data presented for the river and lake are derived from water samples 
collected in the effluent of the WWTP, at six sites along River Fyris, and at 
different locations and depths in Lake Mälaren (Figure 1). Detailed information 
of sampling locations, times, and frequencies are presented in papers I, II, III, 
and V. 
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Figure 1. Sampling locations in River Fyris and Lake Mälaren. 
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5.2  Greater Montreal Region, Canada 
Samples were collected in four rivers serving as the water sources for drinking 
water productions in the Greater Montreal region. Mille-Iles River receives 
effluents of several WWTPs, CSOs, and storm water discharges. Among the 
four rivers, Mille-Iles has the highest total organic carbon (TOC) (7.4 ± 0.5 mg 
L
-1), turbidity (14.9 ± 17.9 NTU), fecal contamination (494.5 ± 600.5 cfu 100 
mL
-1), but the lowest average water flow rate (199 ± 157 m
3 s
-1) (supplementary 
material in paper IV).  The Des Prairies River receives CSOs and storm water 
discharges and has comparable TOC (7.3 ± 0.4 mg L
-1), lower turbidity (8.4 ± 
6.4 NTU), lower fecal contamination (20.8 ± 11.9 cfu 100 mL
-1), and higher 
average water flow rate (1104 ± 399 m
3 s
-1) compared to Mille-Iles River. The 
L’Assomption River receives the discharge of urban and agricultural wastes, 
and has lower TOC (6.0 ± 0.5 mg L
-1), lower turbidity (7.7 ± 2.3 NTU), and 
lower water flow rate (23.9 ± 20.4 m
3 s
-1) compared to the Mille-Iles and Des 
Prairies rivers. The St. Lawrence River receives water mainly from the Great 
Lakes and has the lowest TOC (3.0 ± 0.3 mg L
-1), turbidity (2.2 ± 2.4 NTU), 
fecal coliform (3.0 ± 4.1 cfu 100 mL
-1), but the highest average water flow rate 
(8185 ± 1130 m
3  s
-1) compared to the other three rivers. The differences 
between these rivers in terms of water flow rates, contamination sources, and 
TOC provide us with a unique opportunity to compare variability in the 
upstream-downstream concentrations of different classes of compounds and to 
assess the potential of chemical indicators as a complement to classic microbial 
indicators to track fecal contamination in drinking water sources. Data 
presented for these rivers represent water samples collected in the influent and 
effluent of two WWTPs in Mille-Iles River as well as seven sources of 
drinking water productions in the four rivers (Figure 2). Detailed information 
of sampling times and frequencies is discussed in paper IV. 40 
 
Figure 2. Sampling Locations in Mille-Iles, Des Prairies, L’Assomption, and St. Lawrence 
Rivers. 
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6 Analytical  Methods 
The pharmaceutical residues in the water were either extracted by an off-line or 
an on-line solid-phase extraction (SPE) technique. The detection and 
quantification were performed by a tandem mass spectrometry (MS) system 
coupled to a liquid chromatographic (LC) column. In this chapter, a short 
summary of the sample preparation and analytical methods is provided. The 
reader is, however, encouraged to read the specific paper in the appendix for 
full details.  
6.1  Sample Preparation (Papers I-V) 
In both off-line and on-line SPE/LC-MS-MS methods, sample preparations 
were quite similar. Colloidal and particulate matter in the water samples were 
filtered either through a 0.7-µm glass-fiber followed by 0.45-µm mixed 
cellulose membranes or 0.45-µm mixed cellulose membranes, depending on 
the amount of humic substances present. To prevent degradation of the studied 
compounds and improve their retention on SPE materials, the pH of the 
samples was adjusted to either ~2 or ~10 (Table 3). To minimize the 
uncertainty in quantification due to ion suppression or enhancement resulting 
from a high amount of matrix components, suitable internal standards were 
added to the samples.  
6.2  Off-line SPE/LC-MS-MS (Papers I, II, III, V) 
The off-line method was used in the analyses of pharmaceuticals in all the 
study sites in Sweden (Figure 1). Due to differences in physico-chemical 
properties of the pharmaceuticals, they were divided into two groups, i.e. acidic 
and basic/neutral, where SPE materials, elution solvents, material and mobile 
phase in LC separation columns, and detection method differed (Table 3).  42 
During off-line SPE step, developed by Lindqvist et al. (2005) and Vieno et 
al. (2006), 500 mL of water sample was passed through the SPE material, dried 
with nitrogen gas, and eluted with appropriate organic solvent. The resulting 
extract was evaporated over a gentle nitrogen stream, and diluted with the 
aqueous LC eluent to a final volume 500 µL. 30 µL of each extract was 
injected to a LC-system where it passed through a guard column followed by 
the LC column. The target compounds were eluted from the LC column using 
a linear binary gradient elution method and were detected with a triple-
quadrupole mass spectrometer. The guard column, the LC column, and the 
binary gradients were not exactly identical to those used in the previous studies 
and therefore the method was validated in terms of absolute and relative 
recoveries as well as intraday and interday repeatability.  
6.3  On-line SPE/LC-MS-MS (Paper IV) 
Previously developed on-line SPE/LC-MS-MS methods, validated for the same 
matrix constitutes (Viglino et al., 2008a; Viglino et al., 2008b), were used to 
quantify PPCPs, triazines and their metabolites, and hormones in water 
samples collected in the Greater Montreal region in Canada. In this method, 
only 1 mL of a water sample was preconcentrated while passing through an 
online SPE column and a pump, controlled automatically by an on-line setup. 
The rest of the procedures were almost similar to the off-line SPE/LC-MS-MS 
method (section 6.2), with slight differences in LC separation column and 
ionization sources (Table 3). Due to the elimination of several steps in on-line 
SPE, namely evaporation, reconstitution, and injection, the whole analysis time 
for each sample in the on-line method was a couple of hours shorter than for 
the off-line method.  
6.4 Quantification  (Papers  I-V) 
Independent of the analytical method chosen, the target compounds were 
quantified by the use of two internal standard-based calibration curves, one in 
surface water and one in wastewater, for each sampling occasion. The 
calibration curve samples were set up by spiking with the appropriate amount 
of each compound together with isotopically-labeled internal standards and 
were analyzed using the same procedure as for the water samples.  
 
 
  
Table 3. Analytical methods used in the environmental analyses of the target compounds. 
Analyzed compounds  SPE  LC  Detection method  Paper 
 Mode  pH  Elution 
solvent 
Separation 
column 
Mobile phase     
IBU, NAP, KET, DIC, BEZ  Off-line  2.0  Acetone  C18  NH4OH/ACN  ESI (-), tQ  I, III, V 
ATE, MET, SOT, ACE, CBZ  Off-line  10.0  MeOH  C18  Aq. AA/ACN  ESI (+), tQ  II, III, V 
CAF, TRI, CBZ, NAP, GEM, 
ATR, DEA, DIA, CYA, SIM 
On-line  2.4  MeOH  C18  Aq. FA/MeOH  ESI (+), tQ  IV 
PRO, ESD, ESN  On-line  2.4  MeOH  C18  Aq. FA/MeOH  APPI, tQ  IV 
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7  Results and Discussion 
Three WWTPs, five rivers, and one lake were sampled in Sweden and Canada. 
A total of 14 raw sewage, 30 treated wastewater, 182 river water, and 13 lake 
samples were collected and analyzed in duplicate. 
7.1  Occurrence of Pharmaceuticals and Other Organic 
Pollutants in Treated Wastewaters and Rivers (Papers I-V) 
PPCPs, hormones, and pesticides were detected at least once in the 
analyzed samples from the rivers, whereas in the treated wastewaters some of 
the pesticides and hormones were not detected at all (Table 4 and 5). Mean 
concentrations of pharmaceuticals in the treated wastewater in Sweden ranged 
from 2.4 ng L
-1 for acebutolol to 731 ng L
-1 for diclofenac. In the two WWTPs 
in Canada, caffeine (13755 ng L
-), deethylatrazine (18 ng L
-1), and estrone (274 
ng L
-1) had the highest mean concentrations among the PPCPs, pesticides, and 
hormones, respectively (Table 4). In the Swedish river, mean concentrations of 
pharmaceuticals varied from 0.5 ng L
-1 for acebutolol to 110 ng L
-1 for 
carbamazepine. In the four Canadian rivers, mean concentrations of PPCPs 
ranged between lower than the limit of detection (LOD) for gemfibrozil and 
trimethoprim and 112 ng L
-1 for caffeine. Pesticides ranged between 5 ng L
-1 
for simazine and 53 ng L
-1 for deisopropylatrazine, and hormones ranged 
between 4 ng L
-1 for progesterone and 16 ng L
-1 for estrone (Table 5).  
Although concentrations in the treated wastewaters and surface waters fall 
within previously reported ranges (Table 1), large variations in the 
concentrations were observed between studies. In general, concentrations of 
individual PPCPs and hormones in raw sewage and treated wastewaters reflect 
consumption profile and removal efficiencies, respectively. On the other hand, 
concentrations in surface waters are controlled by the concentration levels of 
point and non-point sources, dilution factor, residence time, and degree of 
attenuation processes. For example, removal efficiencies of ibuprofen in the 46 
Uppsala WWTP (Fick et al., 2011) and the Finnish WWTPs (Lindqvist et al., 
2005) were quite similar whereas mean annual sales of ibuprofen were higher 
in Finland (Lindqvist et al., 2005) compared to the Uppsala region in Sweden 
(Paper I). As a result, mean concentration of ibuprofen in the treated 
wastewaters in Finland (Lindqvist et al., 2005) was higher than the 
corresponding value in the Uppsala WWTP in Sweden (Table 4).  
Table 4. Mean concentrations and standard deviations (SDs) of the target compounds in the 
treated wastewaters in Sweden and Canada. 
Compounds  Sampling 
location 
  Mean ± SD  
(ng L
-1) 
# Positive  paper 
IBU  1 WWTP in River Fyris, SE  117 ± 61  8/15  I, III 
NAP  1 WWTP in River Fyris, SE  232 ± 82  15/15  I, III 
KET  1 WWTP in River Fyris, SE  281 ± 129  15/15  I, III 
DIC  1 WWTP in River Fyris, SE  731 ± 405  15/15  I, III 
BEZ  1 WWTP in River Fyris, SE  336 ± 237  15/15  I, III 
ATE  1 WWTP in River Fyris, SE  309 ± 109  13/13  II, III 
MET  1 WWTP in River Fyris, SE  288 ± 171  13/13  II, III 
SOT  1 WWTP in River Fyris, SE  182 ± 48  13/13  II, III 
ACE  1 WWTP in River Fyris, SE  2.4 ± 2.5  7/13  II, III 
CBZ  1 WWTP in River Fyris, SE  516 ± 178  13/13  II, III 
CAF  2 WWTPs in MI River, CA  13755 ± 12563  13/14  IV 
TRI  2 WWTPs in MI River, CA  66 ± 34  14/14  IV 
CBZ  2 WWTPs in MI River, CA  262 ± 159  14/14  IV 
NAP  2 WWTPs in MI River, CA  1899 ± 1771  14/14  IV 
GEM  2 WWTPs in MI River, CA  95 ± 76  9/14  IV 
ATR  2 WWTPs in MI River, CA  14 ± 10  10/14  IV 
DEA  2 WWTPs in MI River, CA  18 ± 34  7/12  IV 
DIA  2 WWTPs in MI River, CA  Not detected 0/12  IV 
CYA  2 WWTPs in MI River, CA  Not detected 0/12  IV 
SIM  2 WWTPs in MI River, CA  Not detected 0/12  IV 
PRO  2 WWTPs in MI River, CA  <LOD
1 1/6  IV 
ESD  2 WWTPs in MI River, CA  Not detected  0/6  IV 
ESN  2 WWTPs in MI River, CA  274 ± 81  3/6  IV 
1.  LOD for PRO is 3 ng L
-1. 
 
Mean concentration of carbamazepine in the treated wastewater in Sweden 
(516 ng L
-1) was almost two times higher than the mean value in the two 
WWTPs in Canada (262 ng L
-1)
 (Table 4). In River Fyris in Sweden, however, 
mean concentration of carbamazepine was about 15 times higher than the 47 
corresponding value in Mille-Iles River in Canada (Table 5 and supplementary 
material in Paper IV). Considering the level of resistance that carbamazepine 
has to natural attenuation processes (Matamoros et al., 2009; Löffler et al., 
2005), the large variability is most likely a consequence of the 15-times higher 
average water flow rate in River Mille-Iles (199 m
3 s
-1) compared to River 
Fyris (13 m
3 s
-1). 
Table 5. Mean concentrations and SDs of the target compounds in the rivers in Sweden and 
Canada. 
Compounds  Sampling 
location 
  Mean ± SD 
(ng L
-1) 
# Positive  paper 
IBU  River Fyris, SE  31 ± 18  13/36  I 
NAP  River Fyris, SE  33 ± 25  36/36  I 
KET  River Fyris, SE  40 ± 40  21/36  I 
DIC  River Fyris, SE  72 ± 36  31/36  I 
BEZ  River Fyris, SE  38 ± 45  36/36  I 
ATE  River Fyris, SE  38 ± 38  30/30  II 
MET  River Fyris, SE  47 ± 61  29/30  II 
SOT  River Fyris, SE  27 ± 27  30/30  II 
ACE  River Fyris, SE  0.5 ± 0.4  12/30  II 
CBZ  River Fyris, SE  110 ± 74  30/30  II 
CAF  MI, DP, AS, SL Rivers, CA  112 ± 134  76/81  IV 
TRI  MI, DP, AS, SL Rivers, CA  <LOD
2 15/81  IV 
CBZ  MI, DP, AS, SL Rivers, CA  5 ± 2  88/89  IV 
NAP  MI, DP, AS, SL Rivers, CA  20 ± 15  41/89  IV 
GEM  MI, DP, AS, SL Rivers, CA  <LOD
3 1/89  IV 
ATR  MI, DP, AS, SL Rivers, CA  24 ± 17  77/89  IV 
DEA  MI, DP, AS, SL Rivers, CA  18 ± 19  38/54  IV 
DIA  MI, DP, AS, SL Rivers, CA  53 ± 27  10/54  IV 
CYA  MI, DP, AS, SL Rivers, CA  9 ± 9  19/54  IV 
SIM  MI, DP, AS, SL Rivers, CA  5 ± 3  27/54  IV 
PRO  MI, DP, AS, SL Rivers, CA  4 ± 2  14/51  IV 
ESD  MI, DP, AS, SL Rivers, CA  6 ± 2  6/51  IV 
ESN  MI, DP, AS, SL Rivers, CA  16   1/51  IV 
1. The mean concentrations in River Fyris represent the average of data collected at 300, 1320, and 6490 m 
downstream the Uppsala WWTP. 
2. LOD for TRI is 9 ng L
-1. 
3. LOD for GEM is 24 ng L
-1. 
 
In Lake Mälaren, where a much higher degree of dilution is expected 
compared to River Fyris, pharmaceuticals, except for carbamazepine, were 48 
either not detected or detected at low concentrations. Carbamazepine was 
found in relatively comparable concentrations at all sampling sites (84-95 ng L
-
1) and in the water column (84-100 ng L
-1 in 0.5-40 m depth) of Lake Mälaren 
(Table III in paper II). Similarly, a low degree of fluctuation in the 
concentrations of this compound was previously reported in the water column 
of Lake Greifensee in Switzerland (30-58 ng L
-1) (Tixier et al., 2003). Both 
observations point to the high persistency of carbamazepine in the aquatic 
environment. 
7.2  Sources of Pharmaceuticals and Other Organic Pollutants in 
Rivers (Papers I-V) 
In order to locate the contamination sources, concentrations of the most 
frequently detected compounds (Table 4 and 5) were compared between 
upstream and downstream of the rivers receiving discharges from WWTPs and 
CSOs. In River Fyris, this was achieved by calculating the ratio of 
concentrations at the effluent discharge point over upstream point. The 
calculated ratios for all the studied compounds were higher than one, i.e. 
ranging from 1.8 for ibuprofen to 62.0 for metoprolol (Figure 3). In addition, at 
all the sampling events, concentrations in the treated wastewaters were higher 
than the corresponding values in the WWTP upstream (supplementary 
materials in Papers I and II). Hence, the Uppsala WWTP has been indicated as 
a major source of pharmaceuticals in this river.  
 
Figure 3. Annual mean concentrations and SDs (ng L
-1) of pharmaceuticals in upstream, 
wastewater effluent, and effluent discharge point in River Fyris. 
However, considering the detection of trace levels of the compounds in the 
river upstream as well as the increase in concentrations of some compounds 49 
after the merging of River Fyris to River Sävja (R6) (paper I and II) - a small 
river without any WWTP - inputs from city runoff, diffuse sources, and septic 
tanks cannot be completely ruled out. In addition, after a large gathering in the 
vicinity of River Fyris close to the upstream site which was accompanied with 
a heavy rainfall, concentrations of the pharmaceuticals increased from a factor 
3.0 for acebutolol to 86 for atenolol (Figure 4). This pointed to the potential 
contribution of an intermittent source to the occurrence of pharmaceuticals in 
surface waters. 
 
Figure 4. Comparison between annual mean concentrations of pharmaceuticals (ng L
-1) at 
upstream site of the Uppsala WWTP with the corresponding values 24 hours after the Uppsala 
Reggae festival in 2008 and 2009. 
In the Canadian rivers, concentrations of caffeine, carbamazepine, 
naproxen, and atrazine increased in the downstream of Mille-Iles River after 
discharges of several WWTPs and CSOs (Figure 5a). This indicated that inputs 
from WWTPs and CSOs are the main sources of contaminations in this river. 
Nevertheless, higher average concentration of atrazine in the downstream of 
this river (26 ng L
-1) (Figure 5a) compared to the treated wastewaters (14 ng L
-
1) (Table 4) pointed to the presence of other sources such as agricultural runoff. 
At a downstream site of Des Prairies River, receiving only CSOs discharges, 
mean concentration of carbamazepine remained relatively constant, mean 
concentrations of caffeine and naproxen increased, and mean concentration of 
atrazine decreased (Figure 5b). This showed that CSOs are potential 
intermittent sources of the PPCPs in this river. Moving toward a downstream 
of St. Lawrence River, receiving only cumulative contaminations from the 
Great Lakes, mean concentration of atrazine remained relatively constant while 
mean concentrations of caffeine and carbamazepine decreased (Figure 5c). 50 
This highlighted the role of cumulative agricultural runoff as a potential source 
of atrazine. 
The results from Sweden and Canada indicate that release of organic 
pollutants into aquatic environments mainly occurs via continuous/intermittent 
and urban/agricultural sources. Hence, to control and minimize discharges of 
these compounds into natural waters, all possible potential sources need to be 
carefully identified and controlled. 
 
Figure 5. Mean concentrations and SDs of selected compounds, upstream and downstream of (a) 
Mille-Iles River (b) Des Prairies River, and (c) St. Lawrence River.51 
7.3  Seasonal Accumulations of Pharmaceuticals in Rivers 
(Papers I, II) 
The effect of seasonal variations on the accumulation of pharmaceuticals was 
evaluated in River Fyris. This was achieved by comparing temporal-spatial 
mass flows of pharmaceuticals, calculated by multiplying concentration and 
water flow rate at different sampling locations and occasions. With the 
exception of bezafibrate, a clear winter accumulation was observed for all the 
compounds with mean mass flows ranging from 9 µg s
-1 for acebutolol to 1809 
µg s
-1 for diclofenac (Table 6). The highest mean mass flow of bezafibrate was 
however measured during the spring season (1122 µg s
-1) (Table 6) when 
effluent mass flow of this compound was also the highest (Figure 2 in paper I). 
The high mass flows during the winter mainly reflect high water flow rates 
during this season (mean flow rate of 22.8 m
3 s
-1) compared to the other 
seasons (mean flow rates of 12.9 m
3 s
-1 in spring, 3.3 m
3 s
-1 in summer, and 2.9 
m
3 s
-1   in fall). In addition, negligible rates of biotransformation and 
phototransformation in winter may also govern higher accumulation of the 
pharmaceuticals during this season.  
Table 6. Mean mass flows and SDs (µg s
-1) of pharmaceuticals in River Fyris. The presented data 
are an average of mass flows at the effluent discharge point as well as 300, 1320, and 6490 m 
downstream the Uppsala WWTP.  
Compounds Spring  Summer  Fall  Winter  Paper 
IBU   Not detected  162 ± 46  Not detected  464 ± 209  I 
NAP    515 ± 438  89 ± 54  150 ± 86  645 ± 481  I 
KET    708 ± 293  177 ± 102  143 ± 130  505 ± 350  I 
DIC    1355 ± 1130  168 ± 95  201 ± 126  1809 ± 1293  I 
BEZ    1122 ± 888  134 ± 134  105 ± 91  465 ± 409  I 
ATE   Not available  113 ± 59  196 ± 110  614 ± 547  II 
MET   Not available  159 ± 78  307 ± 166  268 ± 399  II 
SOT   Not available  94 ± 46  115 ± 62  355 ± 315  II 
ACE   Not available  1 ± 0.5  1 ± 0.4  9 ± 12  II 
CBZ   Not available  467 ± 134  387 ± 145  1503 ± 1229  II 
7.4  Fate of Pharmaceuticals in Rivers (Papers I-V) 
The potential of natural attenuation processes in removing certain 
pharmaceuticals from water column was assessed by quantifying 
pharmaceuticals in samples collected over a distance of 1320 m in a Swedish 
river. Furthermore, to obtain a clearer picture on the extent of pharmaceuticals’ 
transformation/adsorption in natural waters; we compared removal efficiencies 52 
of WWTP-derived pharmaceuticals with the corresponding values for 
nutrients. The results indicated higher yearly median removal efficiencies of 
acidic (42 %) and basic (28 %) pharmaceuticals compared to nutrients (10 %) 
(Figure 6), despite the potential of some nutrients to be additionally 
transformed into gaseous fractions. 
 
Figure 6. Box plot of removal efficiencies (RE%) of acidic pharmaceuticals, basic/neutral 
pharmaceuticals, and nutrients on a distance of 1320 m in River Fyris. If mass flows at the 
downstream site R4 exceed the sum of those at site R1 and R2, RE can become negative.  
Among the basic and neutral pharmaceuticals, the four beta-blockers 
showed substantial higher removal efficiencies compared to carbamazepine, in 
particular during summer/fall (Figure 7). This can be mainly attributed to 
biotransformation and adsorption (paper II). Despite higher median removal 
efficiencies of atenolol compared to nitrate-nitrogen, their removal efficiencies 
in River Fyris were significantly related (R
2 = 0.72), with the highest removal 
in the summer and fall (Figure 3 in paper V). Overall, this study showed that 
natural waters have a high potential for further removal of pharmaceuticals that 
have already passed WWTPs. Also, elimination of pharmaceuticals in WWTPs 53 
could be substantially improved if pharmaceutical natural attenuation processes 
found in surface waters are included in wastewater treatment processes (paper 
V).  
 
Figure 7. Seasonal variations in the loss of pharmaceuticals in River Fyris as a result of natural 
removal processes. Loss is calculated as the ratio of the sum of the mass flows at the upstream of 
the Uppsala WWTP and treated wastewater over the downstream. 
7.5  Indicators of Fecal Contamination in Rivers (Paper IV) 
Fecal coliforms are widely used to assess level of fecal pollution in drinking 
water intakes. However, analysis of fecal indicator bacteria is a time-
consuming process which does not differentiate between human and animal 
fecal sources (Hagedorn & Weisberg, 2009; Glassmeyer et al., 2005; Buerge et 
al., 2003). Therefore, in this work we evaluated the potential of more persistent 
organic pollutants as indicators. This has been done by establishing a 
relationship between the fecal coliforms and the most abundant PPCPs in the 
Canadian rivers and treated wastewaters, i.e. caffeine and carbamazepine 
(Tables 4 and 5). These compounds have also been previously suggested as 
indicators of anthropogenic tracers (Buerge et al., 2003; Metcalfe et al., 
2003b). Looking into downstream sites in the four Canadian rivers (S2, S3, S4, 
and S7 in Figure 2), a positive correlation between concentrations of caffeine 
and fecal coliforms (R
2 = 0.45) was found. The highest concentrations 
corresponded to Mille-Iles River, receiving discharges of several WWTPs and 
CSOs, and the lowest to St. Lawrence River, impacted by cumulative 
contamination load from the Great Lakes (Figure 8). Therefore, we proposed 
caffeine as a potential indicator of recent fecal contamination with a threshold 54 
value of 100 ng L
-1 to be indicative of a source water of <100 cfu 100 mL
-1 
(Figure 8). A linkage between caffeine concentrations and fecal coliforms has 
been recently reported in an urban watershed (Sauvé et al., 2012). 
 
Figure 8. Logarithmic correlation between fecal coliform and caffeine concentrations. The black 
lines represent an arbitrary threshold limit for fecal coliform at 10, 100, and 1000 cfu 100 m L
-1. 
In contrast to caffeine, no clear relationship was noted for carbamazepine 
concentrations and fecal coliforms in the Canadian rivers (Fig 5b in Paper IV). 
Nevertheless, carbamazepine was frequently detected in the Swedish and 
Canadian WWTPs and rivers (Table 4 and 5). In addition, relatively low 
removal of this compound was reported in the Canadian WWTPs (Table 1 in 
Paper IV) as well as the Swedish WWTP (Fick et al., 2011), river (Figure 6 
and 7), and lake (Table 3 in Paper II). As a result, carbamazepine can be a 
promising indicator of cumulative persistent compounds.   
The mean concentration of caffeine in the raw sewage of the two Canadian 
WWTPs located in Mille-Iles River was about 135 times higher than 
carbamazepine (Table 1 in Paper IV) and removal efficiencies of 
carbamazepine in the WWTPs were up to a factor of 99 lower than caffeine. 
Therefore, a high ratio of caffeine/carbamazepine might be indicative of 
discharges of raw sewage into surface waters. 55 
8  Summary of Results 
The main results of this thesis can be summarized as: 
 
 WWTPs and CSOs are the major sources of PPCPs and hormones while 
recent and cumulative agricultural runoff are major sources of pesticides  
(Papers I, II, IV) 
 Caffeine is a promising indicator of recent urban fecal contamination while 
carbamazepine is a good indicator of cumulative persistent compounds 
(Paper IV) 
 A high caffeine to carbamazepine ratio might be indicative of raw sewage 
discharge in rivers (Paper IV) 
 A large outdoor gathering in the vicinity of surface waters can occasionally 
be a greater source of pharmaceuticals in surface waters than a WWTP 
(Paper III) 
 River flow rates, nature of contamination sources, i.e. urban versus 
agricultural and continuous/intermittent versus cumulative,  and natural 
attenuation processes are the major factors controlling the relative 
frequency of detection, concentrations, and mass flows of PPCPs, 
hormones, and pesticides in natural waters (Papers I-V) 
 Natural waters have a high potential for further removal of WWTP-derived 
pharmaceuticals and removal efficiencies depend on the compound and/or 
seasonal variations, e.g. in River Fyris beta-blockers have the highest 
removal during summer/fall and the lowest during the winter (Papers I-V) 
 Yearly median removal efficiencies of the pharmaceuticals were higher 
than the nutrients. However, median removal efficiencies of atenolol and 
NO3-N were significantly related over the course of a year with the highest 
removal in summer and fall (Paper V) 
 
  
 57 
9  Conclusions and Future Work 
In this section I present the major conclusion of the thesis as well as questions 
and issues that have arisen during the course of this work which need to be 
further addressed.  
Concentrations of pharmaceuticals and caffeine in the treated wastewaters 
of the Swedish and Canadian WWTPs as well as rivers fall partially within the 
reported data from other countries, except for acebutolol and sotalol. While 
concentrations of acebutolol in the Swedish WWTP were lower than the 
reported data, concentrations of sotalol in the Swedish river were higher.  
In both Sweden and Canada, WWTPs were shown to be the main sources of 
contaminations in the studied rivers, similar to previous findings. Based on the 
amount of sales, excretion rates, and removal efficiencies of individual 
compounds in WWTPs, it might be possible to theoretically estimate effluent 
concentrations. However, due to an increasing trend toward buying over-the-
counter drugs through online retailers rather than pharmacies, it might not be 
possible to trace the amount of drug sales. Consequently, this approach may 
give rise to a major underestimation of drug concentrations in treated 
wastewaters. 
Although several publications are available that describe the occurrence of 
drugs in WWTPs and different aquatic compartments, sufficient data from 
middle-income countries are not available. In addition, most of the target 
compounds in the publications were selected based on sales data rather than 
their potential behavioral disturbances to aquatic organisms. For example, there 
are twice as much data available for the occurrence of over-the-counter 
pharmaceuticals in surface and treated wastewater, e.g. ibuprofen (more than 
50 studies in 20 countries), compared to more persistent and toxicologically 
concerned compounds such as natural and synthetic hormones (about 25 
studies in 10 countries).  58 
Water flow rates can vary significantly both temporarily and spatially, 
hence interpretation of mass flow and corresponding removal efficiency of 
individual compounds in natural waters based on mean water flow rate for the 
whole river should be considered carefully.  
Considering the low degree of natural attenuation processes in wintertime, 
in particular biotransformation and phototransformation, removal efficiencies 
of drugs in natural waters are expected to be lower during this season 
compared to the rest of the year. The current knowledge on the extent of 
different attenuation mechanisms of compounds in surface waters is very 
limited and the available data are mainly based on bench scale studies where it 
is difficult to reproduce similar conditions as natural systems. Hence, there is a 
need to perform further studies in different geographical regions, where 
differences in temperature, precipitation, and sunlight availability could result 
in unexpected temporal and spatial removal patterns. Furthermore, in order to 
gain a better understanding of the role of individual mechanisms, abiotic and 
biotic variables such as water residence time, suspended solids, lights intensity, 
temperature, and characteristic of microbial community should be carefully 
monitored at the time of sampling.  
Given the high variability in drug consumption, efficiencies of treatment 
processes, and environmental factors, concentrations and fate of caffeine and 
fecal coliforms are subject to change. Therefore, prior to the consideration of 
caffeine as an indicator of recent fecal contaminations, correlation between 
caffeine and fecal coliforms needs to be confirmed in different geographical 
regions. Similar approaches should be applied when caffeine to carbamazepine 
ratio is used to evaluate discharge of raw sewage into surface waters.  
To develop new policy and legislation for implementing appropriate tools to 
identify sanitary contaminations and for setting allowable levels for the 
discharge of compounds into natural waters, uncertainty in their spatiotemporal 
levels and role of different natural attenuation mechanisms should be tackled 
more closely and be coupled with knowledge of environmental risk associated 
with mixture effect. 
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